Study of Sunitinib Administered as 4/2 vs. 2/1 Schedule in Advanced Renal Cell Carcinoma (RCC)

Clinical trial NCT00570882 · COMPLETED

Trial details

NCT number: NCT00570882
Sponsor: Asan Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma

Start date: 2007-10-01
Primary completion: 2014-06-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.